H U Group HoldingsTSE:4544 +0.99%67 EV-to-FCF is 13.07 as of Jul. 08, 2026, which is 11% above its 10-year median of 11.74. GuruFocus rates TSE:4544 with a GF Score™ of 67/100 and a GF Value™ of 円2,774.93 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 98 Medical Diagnostics & Research companies, H U Group Holdings ranks better than 72.45% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, H U Group Holdings's Enterprise Value is 円218,230 Mil.
H U Group Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was 円16,703 Mil. Therefore, H U Group Holdings's EV-to-FCF for today is 13.07.
The historical rank and industry rank for H U Group Holdings's EV-to-FCF or its related term are showing as below:
TSE:4544'
s EV-to-FCF Range Over the Past 10 Years
Min: -563.02 Med: 11.74 Max: 812.34
Current: 12.95
During the past 13 years, the highest EV-to-FCF of H U Group Holdings was 812.34. The lowest was -563.02. And the median was 11.74.
TSE:4544's EV-to-FCF is ranked better than 72.45% of 98
companies
in the Medical Diagnostics & Research industry
Industry Median: 22.815
vs TSE:4544: 12.95
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
H U Group Holdings (TSE:4544) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
H U Group Holdings's PE Ratio (TTM) for today is calculated as:
H U Group Holdings's share price for today is 円3470.00.
H U Group Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円121.520.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
H U Group Holdings EV-to-FCF Related Terms
H U Group Holdings EV-to-FCF Historical Data
* Premium members only.
The historical data trend for H U Group Holdings's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, H U Group Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
H U Group Holdings EV-to-FCF vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, H U Group Holdings's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where H U Group Holdings's EV-to-FCF falls into.
H U Group Holdings's current Enterprise Value is 円218,230 Mil.
H U Group Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円16,703 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
H U Group Holdings (TSE:4544) has a EV-to-FCF of 13.07 as of Jul. 08, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on H U Group Holdings and its competitors. This is 11% above median its historical median of 11.74. According to the industry distribution chart, H U Group Holdings ranks #27 out of 98 companies in the Medical Diagnostics & Research industry, placing it in the top 27.6%.
Is H U Group Holdings' EV-to-FCF too high?
H U Group Holdings' current EV-to-FCF of 13.07 is 11% above median its 10-year median of 11.74. The Medical Diagnostics & Research industry median EV-to-FCF is 22.82. H U Group Holdings' value of 13.07 is 42.7% below this industry median. Based on the distribution chart, H U Group Holdings ranks #27 out of 98 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, H U Group Holdings has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does H U Group Holdings' EV-to-FCF compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, H U Group Holdings ranks #27 out of 98 companies for EV-to-FCF. This puts H U Group Holdings in the upper half of its industry. The industry median EV-to-FCF is 22.82. H U Group Holdings' value of 13.07 is 42.7% below this benchmark. While the company's 10-year median is 11.74 vs. the industry median of 22.82, H U Group Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Diagnostics & Research company?
The median EV-to-FCF among Medical Diagnostics & Research companies is 22.82, based on 98 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. H U Group Holdings's current EV-to-FCF of 13.07 is 42.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on H U Group Holdings and its competitors. For the Medical Diagnostics & Research industry, the median EV-to-FCF is 22.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. H U Group Holdings's current EV-to-FCF is 13.07, which is 11% above median its own 10-year median of 11.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H U Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, H U Group Holdings (TSE:4544) is currently considered Modestly Overvalued. The stock's GF Value™ is 円2,774.93, compared to a current price of 円3,470.00 — trading 25% above its estimated fair value. The current EV-to-FCF is 13.07, which is 11% above median its 10-year median of 11.74 and 42.7% below the Medical Diagnostics & Research industry median of 22.82. H U Group Holdings' overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For H U Group Holdings (TSE:4544), the current EV-to-FCF is 13.07 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is H U Group Holdings (TSE:4544) Overvalued in 2026?
Based on GuruFocus' analysis, H U Group Holdings stock appears to be overvalued.
The current stock price of 円3,470.00 is trading 25% above its estimated GF Value™ of 円2,774.93.
GuruFocus considers H U Group Holdings to be Modestly Overvalued.
Key valuation signals for TSE:4544:
EV-to-FCF: 13.07 (11% above median its 10-year median of 11.74)
GF Value™: 円2,774.93 vs. price of 円3,470.00 (25% above fair value)
Industry Position: 42.7% below the Medical Diagnostics & Research median (#27 of 98)
No single metric tells the full story. See the TSE:4544 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
H U Group Holdings Inc operates in the healthcare field, focusing on clinical laboratory testing and reagents. The company is engaged in four main businesses. The Clinical Laboratory Testing Business receives samples taken from patients at medical institutions to test for the disease and confirm the condition of the patient's health; In Vitro Diagnostics develops, manufactures, and sells testing reagents and equipment inside and outside Japan; Sterilization & Related Services Business provides a range of medical-related services including sterilization; and Emerging New Business & Others is a new business for future growth.
67GF Score
Get the complete analysis for TSE:4544
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4544 has been successfully added to your 
